Results 81 to 90 of about 3,535 (191)

Guideline for Medication Management of Distressing Symptoms in Older Patients Receiving End‐of‐Life Palliative Care

Journal of Evidence-Based Medicine, Volume 19, Issue 3, September 2026.
ABSTRACT Older patients receiving end‐of‐life palliative care often present with multiple geriatric syndromes, frailty, and comorbid symptom burden, resulting in a high risk of medication‐related harm. This guideline focuses on pharmacological management of distressing symptoms in older patients receiving end‐of‐life or hospice‐oriented palliative care,
Daiping Li, Yanwu Yang, Yan Zhang, Jirong Yue, Birong Dong, Meiling Ge, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University   +7 more
wiley   +1 more source

Hydroxychloroquine‐Associated Photosensitivity: A Case Report With Repeat Phototesting

Photodermatology, Photoimmunology &Photomedicine, Volume 42, Issue 6, November 2026.
John Warner‐Levy, Donna Parkin, Jean Ayer   +2 more
wiley   +1 more source

Cyclodextrins as Chiral Selectors in Capillary Electrophoresis—Recent Developments in Understanding Analyte Complexation and Applications in Pharmaceutical Analysis

ELECTROPHORESIS, Volume 47, Issue 8, Page 696-712, August 2026.
Cyclodextrins are the most often applied chiral selectors in CE enantioseparations. In combination with NMR spectroscopy and molecular modeling, studies for an understanding of chiral recognition underlying enantioseparations have been performed.
Gerhard K. E. Scriba
wiley   +1 more source

Investigation of the antiremodeling effects of losartan, mirabegron and their combination on the development of doxorubicin-induced chronic cardiotoxicity in a rat model [PDF]

, 2022
Despite the effectiveness of doxorubicin (DOXO) as a chemotherapeutic agent, dose-dependent development of chronic cardiotoxicity limits its application. The angiotensin-II receptor blocker losartan is commonly used to treat cardiac remodeling of various
Freiwan Marah
core  

Mirabegron [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

Mirabegron as adjuvant treatment for patients with interstitial cystitis/bladder pain syndrome

, 2017
Introduction: Interstitial cystitis/bladder pain syndrome (IC/BPS) patients represent a heterogeneous group with pain and urinary storage symptoms and varying responses to current treatment options. The novel beta-3 agonist, mirabegron, has been shown to
Michael Di Lena, Kerri-Lynn Kelly, J. Curtis Nickel, Victoria Tolls   +3 more
core   +1 more source

Antiarrhythmic effects of mirabegron on ventricular fibrillation in Langendorff-perfused rabbit ventricles

β−3 adrenoceptor (AR) counteracts the β−1 and β−2 ARs and rescues the effects of excessive catecholamines. To test the hypothesis that a β−3 AR agonist (mirabegron) can reverse the effects of isoproterenol (ISO) on ventricular fibrillation (VF), we ...
Chen, Zhenhui, Li, Xiaochun, Sung, Yen-Ling, Chen, Peng-Sheng, Guo, Shuai, Yang, Minjing, Tisdale, James E., Zhang, Liyang, Goldhaber, Joshua I., Rubart, Michael, Liu, Xiao   +10 more
core   +1 more source

Re: Rano Matta, Refik Saskin, Sarah Neu, et al. Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.001

, 2023
We read with interest the article by Matta et al. on predicting the response to mirabegron in patients with overactive bladder (OAB). Mirabegron is a selective agonist of β3-adrenoceptors on detrusor muscle that facilitates filling of the bladder and ...
Li Marzi, Vincenzo, Finazzi Agro', E., Finazzi Agrò, Enrico, Li Marzi, V., Cosimo De Nunzio, Enrico Finazzi Agrò, Simone Albisinni, Albisinni, S., Vincenzo Li Marzi, Rosato, Eleonora, Lombardo, R., De Nunzio, C., Albisinni, Simone, Lombardo, Riccardo, Riccardo Lombardo, Rosato, E., De Nunzio, Cosimo, Eleonora Rosato   +17 more
core   +1 more source

The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy

Therapeutic Advances in Urology, 2018
Urgency is the prevalent and most bothersome symptom of overactive bladder (OAB) and the treatment of urgency is the primary objective in the management of OAB.
Karl-Erik Andersson, Nurul Choudhury, Jean-Nicolas Cornu, Moses Huang, Cees Korstanje, Emad Siddiqui, Philip Van Kerrebroeck   +6 more
doaj   +1 more source

Acute metabolic and cardiovascular effects of mirabegron in healthy individuals [PDF]

, 2019
AIMS: To quantify acute energy expenditure, supraclavicular skin temperature and cardiovascular responses to four doses of the β3-adrenoceptor agonist, mirabegron.
Formosa, MF, Loh, RKC, Reutens, AT, Andrew L. Carey, La Gerche, A, Rebecca K. C. Loh, Anne T. Reutens, Bronwyn A. Kingwell, Melissa F. Formosa, Kingwell, BA, Andre La Gerche, Carey, AL   +11 more
core   +1 more source